Cell-permeable CaaX-peptides affect K-Ras downstream signaling and promote cell death in cancer cells

被引:14
|
作者
Klimpel, Annika [1 ]
Stillger, Katharina [1 ]
Wiederstein, Janica L. [2 ]
Krueger, Marcus [2 ,3 ]
Neundorf, Ines [1 ]
机构
[1] Univ Cologne, Inst Biochem, Zuelpicher Str 47a, D-50674 Cologne, Germany
[2] Univ Cologne, Inst Genet, Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany
[3] Univ Cologne, Ctr Mol Med CMMC, Cologne, Germany
关键词
CaaX motif; cell‐ penetrating peptides; cysteine prenylation; farnesyltransferase; Ras proteins; PENETRATING PEPTIDE; FARNESYLTRANSFERASE INHIBITORS; PRENYLATED PEPTIDES; N-RAS; PROTEIN; KRAS; GERANYLGERANYLTRANSFERASE; LOCALIZATION; ORGANIZATION; ISOPRENOIDS;
D O I
10.1111/febs.15612
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cysteine prenylation is a post-translational modification that is used by nature to control crucial biological functions of proteins, such as membrane trafficking, signal transduction, and apoptosis. It mainly occurs in eukaryotic proteins at a C-terminal CaaX box and is mediated by prenyltransferases. Since the discovery of prenylated proteins, various tools have been developed to study the mechanisms of prenyltransferases, as well as to visualize and to identify prenylated proteins. Herein, we introduce cell-permeable peptides bearing a C-terminal CaaX motif based on Ras sequences. We demonstrate that intracellular accumulation of those peptides in different cells is controlled by the presence of their CaaX motif and that they specifically interact with intracellular prenyltransferases. As proof of concept, we further highlight their utilization to alter downstream signaling of Ras proteins, particularly of K-Ras-4B, in pancreatic cancer cells. Application of this strategy holds great promise to better understand and regulate post-translational cysteine prenylation.
引用
收藏
页码:2911 / 2929
页数:19
相关论文
共 50 条
  • [41] Pancreatic cancer cell radiation survival and prenyltransferase inhibition: The role of K-ras
    Brunner, TB
    Cengel, KA
    Hahn, SM
    Wu, HM
    Fraker, DL
    McKenna, WG
    Bernhard, EJ
    CANCER RESEARCH, 2005, 65 (18) : 8433 - 8441
  • [42] K-ras genotypes and prognosis in non-small-cell lung cancer
    Rosell, R
    Monzo, M
    Molina, F
    Martinez, E
    Pifarre, A
    Moreno, I
    Mate, JL
    deAnta, JM
    Sanchez, M
    Font, A
    ANNALS OF ONCOLOGY, 1995, 6 : 15 - 20
  • [43] Attacking the most downstream "gatekeeper" signaling module in the oncogenic ERBB/K-RAS signaling pathway to block tumorigenesis and metastasis in human cancer
    Bian, Minglei
    Liao, Yang
    Zheleva, Vasilena
    Gao, Xiaofei
    Urban, Zena M.
    Njogu, Monicah M.
    Odanga, Justin J.
    Isbell, Andrew J.
    Schmidt, Rebecca L.
    Takahashi, Rie
    Perry, Roger R.
    Hoefer, Richard A.
    Smyrk, Thomas C.
    Petersen, Gloria M.
    Tang, Amy H.
    CANCER RESEARCH, 2013, 73
  • [44] Principles of K-Ras effector organization and the role of oncogenic K-Ras in cancer initiation through G1 cell cycle deregulation
    Nussinov, Ruth
    Tsai, Chung-Jung
    Muratcioglu, Serena
    Jang, Hyunbum
    Gursoy, Attila
    Keskin, Ozlem
    EXPERT REVIEW OF PROTEOMICS, 2015, 12 (06) : 669 - 682
  • [45] A homologous promoterless K-ras cDNA targeting endogenous K-ras expression inhibits human pancreatic cancer cell growth in vitro and in vivo
    Xin-Yu, Ren
    Zhi-Yong, Liang
    Xiao-Hua, Shi
    Tong-Hua, Liu
    CANCER BIOLOGY & THERAPY, 2008, 7 (10) : 1641 - 1647
  • [46] Cell Signaling Pathways That Promote Radioresistance of Cancer Cells
    Ouellette, Michel M.
    Zhou, Sumin
    Yan, Ying
    DIAGNOSTICS, 2022, 12 (03)
  • [47] Metabolic regulation of EGFR effector and feedback signaling in pancreatic cancer cells requires K-Ras
    Lee, Szu-Wei
    Commisso, Cosimo
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2020, 533 (03) : 424 - 428
  • [48] Regulation of CD137 expression through K-Ras signaling in pancreatic cancer cells
    Glorieux, Christophe
    Huang, Peng
    CANCER COMMUNICATIONS, 2019, 39
  • [49] Activation of cancer stem cells by oncogenic K-Ras requires activated Wnt/β-catenin signaling
    Moon, Byoung-San
    Lee, Kug Hwa
    Koo, Kyounghwa
    Choi, Kang-Yell
    CANCER RESEARCH, 2015, 75
  • [50] K-ras gene mutations in non-small cell lung cancer in Japanese
    Noda, N
    Matsuzoe, D
    Konno, T
    Kawahara, K
    Yamashita, Y
    Shirakusa, T
    ONCOLOGY REPORTS, 2001, 8 (04) : 889 - 892